BioHealth News Archive
2021 Forum Videos are Now Available!
Leaders from the BioHealth Capital Region welcome the over 1,000 registrants to the 7th Annual BioHealth Capital Region Forum. Please visit this link.
Read MoreA US – UK Discussion: How to Conduct Clinical Trials as Seth Toback, Vice President, Clinical Development at Novavax and Divya Chadha Manek, Director of Business Development at the National Institute for Health Research (NIHR) join Rich Bendis on BioTalk.
Listen now via Apple https://apple.co/3BSIFjn, Google https://bit.ly/3j7YyLt, Spotify https://spoti.fi/2Z474Ec, and TuneIn https://bit.ly/3DUweUz. Divya Chadha Manek was appointed as the NIHR CRN’s Head of Commercial Business Development in 2015 then…
Read MoreLife Sciences Business Strategist – Open Position!
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia). BHI…
Read MoreMapping the Medical Device Start-up Ecosystem | by John G Younger | Bioeconomy.XYZ | Oct, 2021 | Medium
Medical devices are ubiquitous in US healthcare— everything from the delivery room’s sterile gloves and umbilical cord clamps to the breathtakingly sophisticated neurosurgical operating…
Read MoreDistrust, Fear Hamper COVID Vaccinations, Clinical Trial Diversity
TYSONS CORNER, Va., Oct. 12, 2021 /PRNewswire-PRWeb/ -- As of late September, 77% of the total adult population of the U.S. had received at…
Read MoreGrand Opening at USM Southern Maryland (USMSM) Celebrates New, $86 Million ‘SMART’ Innovation Center to Expand Educational Opportunities, Autonomous Vehicles Research – USM
Baltimore, Md. (Oct. 12, 2021) – State of Maryland leaders will join University System of Maryland (USM) Chancellor Jay A. Perman at 1 p.m.…
Read MoreFull Interview: Nearly True Tales of Innovation – Jennifer McCaney & Kwame Ulmer – YouTube
Benjamin Glenn of A Matter of Innovation sits down with Jennifer McCaney PhD, (Co-Executive Director UCLA Biodesign) and Kwame Ulmer, MD (Venture Partner Wavemaker…
Read MoreIn Conversation: John Mumm, Chief Executive Officer, Deka Biosciences · BioBuzz
John Mumm, the chief executive officer of Germantown’s Deka Biosciences, describes the body’s immune system as a ballet. While the dancers take the stage…
Read MoreTips for Small Business Applicants | National Institute on Aging
What Does a Successful Submission Look Like? Offers Innovative solutions to a significant unmet clinical need Provides solutions that have significant commercial potential Corresponds…
Read MoreNational Science Foundation Issues Small Business Innovation Research (SBIR) Grant to The Wrightguard Innovations Corporation in Support of Novel Mouthguard Technology
BALTIMORE, Oct. 14, 2021 /PRNewswire/ -- The Wrightguard Innovations Corporation (TWGIC), a University of Maryland, Baltimore (UMB) startup company developing smart mouthguard technology designed…
Read MoreQ3 2021 PitchBook-NVCA Venture Monitor | PitchBook
Exits top $582 billion as US VC continues its extraordinary year In nine months, the US venture capital industry turned 2021 into a year…
Read MorePionieren in de Polder – Miniatuurorganen op een chip (Paul Vulto co-founder of BHI client MIMETAS)
For our Dutch-speaking following, there is a podcast available with our CEO Paul Vulto. In this podcast series “Pioneren in de polder”, different entrepreneurs talk…
Read MoreEmergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP | Emergent BioSolutions Inc.
GAITHERSBURG, Md., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the first participant dosed in its pivotal phase 3 study…
Read MoreBHI EIR Feedback Day October 27th. Register Now! (2)
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreSupernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio – Supernus Pharmaceuticals
ROCKVILLE, Md. and EMERYVILLE, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) and Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), today announced…
Read More